Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study

Study (n=1,193 reports of exposure, mean duration 5.3 weeks) finds that although reports are missing important details & predominantly describe rivaroxaban exposures, available data do not suggest direct oral anticoagulant exposure in pregnancy carries a high risk of embryopathy

The Lancet Haematology